Trevi Therapeutics, INC. 8-K Filing
Ticker: TRVI · Form: 8-K · Filed: Dec 5, 2025 · CIK: 1563880
Sentiment: neutral
Filing Stats: 897 words · 4 min read · ~3 pages · Grade level 11.3 · Accepted 2025-12-05 08:58:00
Key Financial Figures
- $0.001 — e on which registered Common stock, $0.001 par value per share TRVI The Nasdaq
- $522,000 — er things, an annualized base salary of $522,000, and an annual incentive bonus of up to
Filing Documents
- trvi-20251201.htm (8-K) — 55KB
- 0001193125-25-308769.txt ( ) — 165KB
- trvi-20251201.xsd (EX-101.SCH) — 28KB
- trvi-20251201_htm.xml (XML) — 5KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TREVI THERAPEUTICS, INC. Date: December 5, 2025 By: /s/ Jennifer L. Good Name: Jennifer L. Good Title: President and Chief Executive Officer